ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.151,27
-0,10%
S&P 500
5.293,28
-0,07%
US Dollar vs BRL
5,1081
-0,43%
Bitcoin
66.346,08
1,70%
Brent Oil
83,735
0,64%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. DermTech Inc (DMTK)

  7. DermTech Inc (DMTK) Notícias

DMTK

DermTech (DMTK)

DermTech Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DMTK
DataHoraFonteTítuloCódigoCompanhia
14/05/202417:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMTKDermTech Inc
14/05/202417:05Business WireDermTech Reports First-Quarter 2024 Financial ResultsNASDAQ:DMTKDermTech Inc
18/04/202417:15Business WireDermTech to Explore Strategic Alternatives and Implement Restructuring PlanNASDAQ:DMTKDermTech Inc
01/04/202417:05Business WireDermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMTKDermTech Inc
08/03/202410:05Business WireDermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative DermatologyNASDAQ:DMTKDermTech Inc
07/03/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMTKDermTech Inc
07/03/202418:17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DMTKDermTech Inc
29/02/202418:53Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DMTKDermTech Inc
29/02/202418:01Business WireDermTech Reports Fourth-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
13/02/202410:05Business WireDermTech Announces Release Date for Fourth-quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
31/01/202418:30Business WireDermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline OperationsNASDAQ:DMTKDermTech Inc
18/01/202410:05Business WireDermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin TypesNASDAQ:DMTKDermTech Inc
16/01/202410:05Business WireDermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on AssayNASDAQ:DMTKDermTech Inc
08/01/202410:00Business WireDermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
04/12/202307:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK)NASDAQ:DMTKDermTech Inc
02/11/202317:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMTKDermTech Inc
02/11/202317:01Business WireDermTech Reports Third-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
12/10/202309:05Business WireDermTech Announces Release Date for Third-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
22/09/202321:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMTKDermTech Inc
21/09/202317:05Business WireDermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:DMTKDermTech Inc
19/09/202309:05Business WireDermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
11/09/202309:05Business WireDermTech Appoints Mark Aguillard as Chief Commercial OfficerNASDAQ:DMTKDermTech Inc
11/08/202319:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DMTKDermTech Inc
03/08/202317:01Business WireDermTech Reports Second-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
19/07/202309:00Business WireDermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
17/07/202309:00Business WireDermTech Announces Release Date for Second-Quarter 2023 Financial ResultsNASDAQ:DMTKDermTech Inc
13/07/202317:09Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DMTKDermTech Inc
12/07/202309:00Business WireDermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
28/06/202317:30Business WireDermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline OperationsNASDAQ:DMTKDermTech Inc
14/06/202309:00Business WireECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)NASDAQ:DMTKDermTech Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:DMTK

Seu Histórico Recente

BOV
GFSA3
GAFISA ON
BOV
IBOV
Índice Bovespa
BOV
HBOR3
HELBOR ON
BOV
OIBR3
OI ON
BOV
PRIO3
PETRORIO ON
BOV
ENAT3
ENAUTA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
AMAR3
LOJAS MARISA ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
OPCT3
Oceanpact Servicos Marit... ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
IRBR3
IRB BRASIL ON
BOV
LIGT3
LIGHT ON
BOV
COGN3
COGNA ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GOLL4
GOL PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados